Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, modest growth trend.
Left:
||||
Free cash flow yield
Latest
-23.52%
↓ 59% below average
Average (9y)
-14.77%
Historical baseline
Range
High:0.33%
Low:-29.59%
CAGR
+4.9%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -23.52% | -51.4% |
| 2023 | -15.54% | -4877.7% |
| 2022 | 0.33% | +105.5% |
| 2021 | -5.93% | +20.9% |
| 2020 | -7.50% | +70.0% |
| 2019 | -25.00% | +15.5% |
| 2018 | -29.59% | -128.7% |
| 2017 | -12.94% | -1.3% |
| 2016 | -12.77% | +16.3% |
| 2015 | -15.26% | - |